Lactobacillus rhamnosus (LGG) Regulates IL-10 Signaling in the Developing Murine Colon through Upregulation of the IL-10R2 Receptor Subunit

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Mirpuri, Julie ^a,b   Sotnikov, Ilya ^a   Myers, Loren ^a   Denning, Timothy L ^a   Yarovinsky, Felix ^c   Parkos, Charles A ^a   Denning, Patricia W ^a   Louis, Nancy A ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CELL RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 10R2 RECEPTOR; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 2; MESSENGER RNA; PROBIOTIC AGENT; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BACTERIAL COLONIZATION; COLON; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE MARKER; DISEASE SEVERITY; DOWN REGULATION; INFECTION RISK; LACTOBACILLUS RHAMNOSUS; MOUSE; NECROTIZING ENTEROCOLITIS; NONHUMAN; PERINATAL PERIOD; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; CHEMOKINE CXCL2; COLON; CYTOKINES; ENTEROCOLITIS, NECROTIZING; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-10; INTERLEUKIN-10 RECEPTOR BETA SUBUNIT; INTESTINES; LACTOBACILLUS RHAMNOSUS; LIPOPOLYSACCHARIDES; MICE; PHOSPHORYLATION; PLATELET ACTIVATING FACTOR; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TUMOR NECROSIS FACTOR-ALPHA; WEANING;

LACTOBACILLUS RHAMNOSUS; MURINAE; MUS;

EID: 84871316728     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051955     Document Type: Article

References (73)

1. Frost BL, Jilling T, Caplan MS, (2008) The importance of pro-inflammatory signaling in neonatal necrotizing enterocolitis. Semin Perinatol 32: 100-106.
2. Lin PW, Nasr TR, Stoll BJ, (2008) Necrotizing enterocolitis: recent scientific advances in pathophysiology and prevention. Semin Perinatol 32: 70-82.
3. de la Cochetiere MF, Piloquet H, des Robert C, Darmaun D, Galmiche JP, et al. (2004) Early intestinal bacterial colonization and necrotizing enterocolitis in premature infants: the putative role of Clostridium. Pediatr Res 56: 366-370.
4. Neish AS, Gewirtz AT, Zeng H, Young AN, Hobert ME, et al. (2000) Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science 289: 1560-1563.
5. Hobbie S, Chen LM, Davis RJ, Galan JE, (1997) Involvement of mitogen-activated protein kinase pathways in the nuclear responses and cytokine production induced by Salmonella typhimurium in cultured intestinal epithelial cells. J Immunol 159: 5550-5559.
6. Jilling T, Simon D, Lu J, Meng FJ, Li D, et al. (2006) The roles of bacteria and TLR4 in rat and murine models of necrotizing enterocolitis. J Immunol 177: 3273-3282.
7. Hunter CJ, Williams M, Petrosyan M, Guner Y, Mittal R, et al. (2009) Lactobacillus bulgaricus prevents intestinal epithelial cell injury caused by Enterobacter sakazakii-induced nitric oxide both in vitro and in the newborn rat model of necrotizing enterocolitis. Infect Immun 77: 1031-1043.
8. Lin PW, Myers LE, Ray L, Song SC, Nasr TR, et al. (2009) Lactobacillus rhamnosus blocks inflammatory signaling in vivo via reactive oxygen species generation. Free Radic Biol Med 47: 1205-1211.
9. Patel RM, Myers LS, Kurundkar AR, Maheshwari A, Nusrat A, et al. (2012) Probiotic bacteria induce maturation of intestinal claudin 3 expression and barrier function. Am J Pathol 180: 626-635.
10. Liedel JL, Guo Y, Yu Y, Shiou SR, Chen S, et al. (2011) Mother's milk-induced Hsp70 expression preserves intestinal epithelial barrier function in an immature rat pup model. Pediatr Res 69: 395-400.
11. Khailova L, Dvorak K, Arganbright KM, Halpern MD, Kinouchi T, et al. (2009) Bifidobacterium bifidum improves intestinal integrity in a rat model of necrotizing enterocolitis. Am J Physiol Gastrointest Liver Physiol 297: G940-949.
12. Deshpande G, Rao S, Patole S, Bulsara M, (2010) Updated meta-analysis of probiotics for preventing necrotizing enterocolitis in preterm neonates. Pediatrics 125: 921-930.
13. Alfaleh K, Anabrees J, Bassler D, Al-Kharfi T (2011) Probiotics for prevention of necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev: CD005496.
14. Tan X, Hsueh W, Gonzalez-Crussi F, (1993) Cellular localization of tumor necrosis factor (TNF)-alpha transcripts in normal bowel and in necrotizing enterocolitis. TNF gene expression by Paneth cells, intestinal eosinophils, and macrophages. Am J Pathol 142: 1858-1865.
15. Huang L, Tan X, Crawford SE, Hsueh W, (1994) Platelet-activating factor and endotoxin induce tumour necrosis factor gene expression in rat intestine and liver. Immunology 83: 65-69.
16. Halpern MD, Clark JA, Saunders TA, Doelle SM, Hosseini DM, et al. (2006) Reduction of experimental necrotizing enterocolitis with anti-TNF-alpha. Am J Physiol Gastrointest Liver Physiol 290: G757-764.
17. Sun X, Caplan MS, Hsueh W, (1994) Tumour necrosis factor and endotoxin synergistically activate intestinal phospholipase A2 in mice. Role of endogenous platelet activating factor and effect of exogenous platelet activating factor. Gut 35: 215-219.
18. Han XB, Liu X, Hsueh W, De Plaen IG, (2004) Macrophage inflammatory protein-2 mediates the bowel injury induced by platelet-activating factor. Am J Physiol Gastrointest Liver Physiol 287: G1220-1226.
19. Harris MC, Costarino AT Jr, Sullivan JS, Dulkerian S, McCawley L, et al. (1994) Cytokine elevations in critically ill infants with sepsis and necrotizing enterocolitis. J Pediatr 124: 105-111.
20. Morecroft JA, Spitz L, Hamilton PA, Holmes SJ (1994) Plasma cytokine levels in necrotizing enterocolitis. Acta Paediatr Suppl 396: 18-20.
21. Halpern MD, Holubec H, Dominguez JA, Williams CS, Meza YG, et al. (2002) Up-regulation of IL-18 and IL-12 in the ileum of neonatal rats with necrotizing enterocolitis. Pediatr Res 51: 733-739.
22. Rajasingh J, Bord E, Luedemann C, Asai J, Hamada H, et al. (2006) IL-10-induced TNF-alpha mRNA destabilization is mediated via IL-10 suppression of p38 MAP kinase activation and inhibition of HuR expression. FASEB J 20: 2112-2114.
23. Smallie T, Ricchetti G, Horwood NJ, Feldmann M, Clark AR, et al. (2010) IL-10 inhibits transcription elongation of the human TNF gene in primary macrophages. J Exp Med 207: 2081-2088.
24. Kasama T, Strieter RM, Lukacs NW, Lincoln PM, Burdick MD, et al. (1995) Interleukin-10 expression and chemokine regulation during the evolution of murine type II collagen-induced arthritis. J Clin Invest 95: 2868-2876.
25. Standiford TJ, Strieter RM, Lukacs NW, Kunkel SL, (1995) Neutralization of IL-10 increases lethality in endotoxemia. Cooperative effects of macrophage inflammatory protein-2 and tumor necrosis factor. J Immunol 155: 2222-2229.
26. Kopydlowski KM, Salkowski CA, Cody MJ, van Rooijen N, Major J, et al. (1999) Regulation of macrophage chemokine expression by lipopolysaccharide in vitro and in vivo. J Immunol 163: 1537-1544.
27. de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE, (1991) Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209-1220.
28. Aste-Amezaga M, Ma X, Sartori A, Trinchieri G, (1998) Molecular mechanisms of the induction of IL-12 and its inhibition by IL-10. J Immunol 160: 5936-5944.
29. McInnes IB, Gracie JA, Leung BP, Wei XQ, Liew FY, (2000) Interleukin 18: a pleiotropic participant in chronic inflammation. Immunol Today 21: 312-315.
30. Mirpuri J, Brazil JC, Berardinelli AJ, Nasr TR, Cooper K, et al. (2010) Commensal Escherichia coli reduces epithelial apoptosis through IFN-alphaA-mediated induction of guanylate binding protein-1 in human and murine models of developing intestine. J Immunol 184: 7186-7195.
31. Louis NA, Robinson AM, MacManus CF, Karhausen J, Scully M, et al. (2008) Control of IFN-alphaA by CD73: implications for mucosal inflammation. J Immunol 180: 4246-4255.
32. Rakoff-Nahoum S, Medzhitov R, (2008) Innate immune recognition of the indigenous microbial flora. Mucosal Immunol 1Suppl 1: S10-14.
33. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W, (1993) Interleukin-10-deficient mice develop chronic enterocolitis. Cell 75: 263-274.
34. Chokshi NK, Guner Y, Ford HR, (2008) The role of IL-10 in experimental Necrotizing Enterocolitis (NEC). Journal of the American College of Surgeons 207: S14-S15.
35. Madsen KL, Fedorak RN, Tavernini MM, Doyle JS, (2002) Normal Breast Milk Limits the Development of Colitis in IL-10-Deficient Mice. Inflamm Bowel Dis 8: 390-398.
36. Emami CN, Chokshi N, Wang J, Hunter C, Guner Y, et al. (2012) Role of interleukin-10 in the pathogenesis of necrotizing enterocolitis. Am J Surg 203: 428-435.
37. Lucas A, Cole TJ, (1990) Breast milk and neonatal necrotising enterocolitis. Lancet 336: 1519-1523.
38. Garofalo R, Chheda S, Mei F, Palkowetz KH, Rudloff HE, et al. (1995) Interleukin-10 in human milk. Pediatr Res 37: 444-449.
39. Greig PC, Herbert WN, Robinette BL, Teot LA, (1995) Amniotic fluid interleukin-10 concentrations increase through pregnancy and are elevated in patients with preterm labor associated with intrauterine infection. Am J Obstet Gynecol 173: 1223-1227.
40. Donnelly RP, Dickensheets H, Finbloom DS, (1999) The interleukin-10 signal transduction pathway and regulation of gene expression in mononuclear phagocytes. J Interferon Cytokine Res 19: 563-573.
41. Liu Y, Wei SH, Ho AS, de Waal Malefyt R, Moore KW, (1994) Expression cloning and characterization of a human IL-10 receptor. J Immunol 152: 1821-1829.
42. Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, et al. (1997) Identification and functional characterization of a second chain of the interleukin-10 receptor complex. EMBO J 16: 5894-5903.
43. Denning TL, Campbell NA, Song F, Garofalo RP, Klimpel GR, et al. (2000) Expression of IL-10 receptors on epithelial cells from the murine small and large intestine. Int Immunol 12: 133-139.
44. Finbloom DS, Winestock KD, (1995) IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1 alpha and STAT3 complexes in human T cells and monocytes. J Immunol 155: 1079-1090.
45. Claud EC, Savidge T, Walker WA, (2003) Modulation of human intestinal epithelial cell IL-8 secretion by human milk factors. Pediatr Res 53: 419-425.
46. Lee J, Rachmilewitz D, Raz E, (2006) Homeostatic effects of TLR9 signaling in experimental colitis. Ann NY Acad Sci 1072: 351-355.
47. Rachmilewitz D, Katakura K, Karmeli F, Hayashi T, Reinus C, et al. (2004) Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis. Gastroenterology 126: 520-528.
48. Murray PJ, (2006) Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr Opin Pharmacol 6: 379-386.
49. Bahjat KS, Meyer-Morse N, Lemmens EE, Shugart JA, Dubensky TW, et al. (2009) Suppression of cell-mediated immunity following recognition of phagosome-confined bacteria. PLoS Pathog 5: e1000568.
50. Chiu BC, Stolberg VR, Freeman CM, Chensue SW, (2007) Mononuclear phagocyte-derived interleukin-10 suppresses the innate pulmonary granuloma cytokine response in aged mice. Am J Pathol 171: 829-837.
51. Hsueh W, Gonzalez-Crussi F, Arroyave JL, (1987) Platelet-activating factor: an endogenous mediator for bowel necrosis in endotoxemia. FASEB J 1: 403-405.
52. Maheshwari A, Kelly DR, Nicola T, Ambalavanan N, Jain SK, et al. (2010) TGF-beta2 Suppresses Macrophage Cytokine Production and Mucosal Inflammatory Responses in the Developing Intestine. Gastroenterology.
53. Sun X, Rozenfeld RA, Qu X, Huang W, Gonzalez-Crussi F, et al. (1997) P-selectin-deficient mice are protected from PAF-induced shock, intestinal injury, and lethality. Am J Physiol 273: G56-61.
54. Edelson MB, Bagwell CE, Rozycki HJ, (1999) Circulating pro- and counterinflammatory cytokine levels and severity in necrotizing enterocolitis. Pediatrics 103: 766-771.
55. Weitkamp JH, Koyama T, Rock MT, Correa H, Goettel JA, et al. (2012) Necrotising enterocolitis is characterised by disrupted immune regulation and diminished mucosal regulatory (FOXP3)/effector (CD4, CD8) T cell ratios. Gut.
56. Ford H, Watkins S, Reblock K, Rowe M, (1997) The role of inflammatory cytokines and nitric oxide in the pathogenesis of necrotizing enterocolitis. J Pediatr Surg 32: 275-282.
57. Ren Y, Lin CL, Li Z, Chen XY, Huang X, et al. (2005) Up-regulation of macrophage migration inhibitory factor in infants with acute neonatal necrotizing enterocolitis. Histopathology 46: 659-667.
58. Fituch CC, Palkowetz KH, Goldman AS, Schanler RJ, (2004) Concentrations of IL-10 in preterm human milk and in milk from mothers of infants with necrotizing enterocolitis. Acta Paediatr 93: 1496-1500.
59. Akisu M, Baka M, Yalaz M, Huseyinov A, Kultursay N, (2003) Supplementation with Saccharomyces boulardii ameliorates hypoxia/reoxygenation-induced necrotizing enterocolitis in young mice. Eur J Pediatr Surg 13: 319-323.
60. Butel MJ, Roland N, Hibert A, Popot F, Favre A, et al. (1998) Clostridial pathogenicity in experimental necrotising enterocolitis in gnotobiotic quails and protective role of bifidobacteria. J Med Microbiol 47: 391-399.
61. Caplan MS, Miller-Catchpole R, Kaup S, Russell T, Lickerman M, et al. (1999) Bifidobacterial supplementation reduces the incidence of necrotizing enterocolitis in a neonatal rat model. Gastroenterology 117: 577-583.
62. Bin-Nun A, Bromiker R, Wilschanski M, Kaplan M, Rudensky B, et al. (2005) Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 147: 192-196.
63. Dani C, Biadaioli R, Bertini G, Martelli E, Rubaltelli FF, (2002) Probiotics feeding in prevention of urinary tract infection, bacterial sepsis and necrotizing enterocolitis in preterm infants. A prospective double-blind study. Biol Neonate 82: 103-108.
64. Hoyos AB, (1999) Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 3: 197-202.
65. De Groote MA, Frank DN, Dowell E, Glode MP, Pace NR, (2005) Lactobacillus rhamnosus GG bacteremia associated with probiotic use in a child with short gut syndrome. Pediatr Infect Dis J 24: 278-280.
66. Zein EF, Karaa S, Chemaly A, Saidi I, Daou-Chahine W, et al. (2008) [Lactobacillus rhamnosus septicemia in a diabetic patient associated with probiotic use: a case report]. Ann Biol Clin (Paris) 66: 195-198.
67. Land MH, Rouster-Stevens K, Woods CR, Cannon ML, Cnota J, et al. (2005) Lactobacillus sepsis associated with probiotic therapy. Pediatrics 115: 178-181.
68. Waeytens A, Ferdinande L, Neirynck S, Rottiers P, De Vos M, et al. (2008) Paracellular entry of interleukin-10 producing Lactococcus lactis in inflamed intestinal mucosa in mice. Inflamm Bowel Dis 14: 471-479.
69. Sasaki A, Yasukawa H, Shouda T, Kitamura T, Dikic I, et al. (2000) CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2. J Biol Chem 275: 29338-29347.
70. Li N, Russell WM, Douglas-escobar M, Hauser N, Lopez M, et al. (2009) Live and heat-killed Lactobacillus rhamnosus GG: effects on proinflammatory and anti-inflammatory cytokines/chemokines in gastrostomy-fed infant rats. Pediatr Res 66: 203-207.
71. Karhausen J, Furuta GT, Tomaszewski JE, Johnson RS, Colgan SP, et al. (2004) Epithelial hypoxia-inducible factor-1 is protective in murine experimental colitis. J Clin Invest 114: 1098-1106.
72. Schnoor M, Betanzos A, Weber DA, Parkos CA, (2009) Guanylate-binding protein-1 is expressed at tight junctions of intestinal epithelial cells in response to interferon-gamma and regulates barrier function through effects on apoptosis. Mucosal Immunol 2: 33-42.
73. Suzuki A, Hanada T, Mitsuyama K, Yoshida T, Kamizono S, et al. (2001) CIS3/SOCS3/SSI3 plays a negative regulatory role in STAT3 activation and intestinal inflammation. J Exp Med 193: 471-481.